Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy.

@article{Suy2006IncreasedRO,
  title={Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy.},
  author={Anna Suy and Esteban Martinez and Oriol Coll and Montserrat Lonc{\'a} and Montserrat Palacio and Elisa de Lazzari and Mar{\'i}a Larrousse and Ana Milinkovi{\'c} and Sandra Hernandez and Jos{\'e} L Blanco and Jos{\'e}p Mallolas and Agathe Le{\'o}n and Juan Antonio Vanrell and Jose M. Gatell},
  journal={AIDS},
  year={2006},
  volume={20 1},
  pages={59-66}
}
BACKGROUND Pre-eclampsia and/or fetal death have increased sharply in HIV-infected pregnant women receiving HAART. METHODS The occurrence of pre-eclampsia or fetal death was analysed in women who delivered after at least 22 weeks of gestation for all women (January 2001 until July 2003) and for HIV-infected women (November 1985 until July 2003). RESULTS In 2001, 2002 and 2003, the rates per 1000 deliveries of pre-eclampsia and fetal death, respectively, remained stable in all pregnant women… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 55 extracted citations

Antiretroviral therapy and preterm birth in HIV-infected women.

Expert review of anti-infective therapy • 2014
View 5 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…